Status:
UNKNOWN
Adverse Drug Reactions of Different Brands of Ceftazidime Injection
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Infection
Eligibility:
All Genders
1-95 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to understand whether generic ceftazidime causes different adverse drug reaction incidence from the brand drug.
Detailed Description
Ceftazidime is a third generation cephalosporins that should be reserved for severe bacterial infections. Substitution of the brand ceftazidime with a generic ceftazidime raised some concerns. The pu...
Eligibility Criteria
Inclusion
- patients in surgical intensive care unit who require ceftazidime treatment
Exclusion
- less than 1 year old
Key Trial Info
Start Date :
March 1 2001
Trial Type :
INTERVENTIONAL
End Date :
April 1 2002
Estimated Enrollment :
536 Patients enrolled
Trial Details
Trial ID
NCT00173901
Start Date
March 1 2001
End Date
April 1 2002
Last Update
September 15 2005
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan, 100